首页> 美国政府科技报告 >Role of Ubiquitin E3 Ligase SCF-SKP2 in Prostate Cancer Development
【24h】

Role of Ubiquitin E3 Ligase SCF-SKP2 in Prostate Cancer Development

机译:泛素E3连接酶sCF-sKp2在前列腺癌发展中的作用

获取原文

摘要

Low or absent expression of CDK inhibitor p27Kip1 is associated with malignant prostatecarcinomas. Loss of tumor suppressors p53 and Pten is also associated with prostate cancers. We found that p27 is regulated byboth SCF-SKP2 and a novel ubiquitin E3 ligase containing CUL4-DDB1-WD40-repeat proteins. In addition, we have identified that a specific CUL4A-DDB1-L2DTL/CDT2-PCNA ubiquitin E3 ligase binds and targets p53 polyubiquitination- dependentproteolysis in cooperation with MDM2. By interacting with a WD40-repeat proteins as asubstrate targetingsubunit, the CUL4-DDB1 ubiquitin E3 ligase regulates a wide array of biological events including cell cycle regulation, genome stability, andhistone methylation;alteration of these events have been shown to associate with the development of prostatecarcinogenesis. We in additionfound that expression of SKP2 and Pten heterozygosity do notcooperate inthe mouse prostate carcinoma models, suggesting that SKP2 may act downstream ofPten pathway. Our work provides novel insights into the mechanism of prostate tumorigenesis.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号